Artificial Intelligence (AI) in the Life Sciences and Healthcare
Artificial Intelligence (AI) has emerged as a global phenomenon in recent years with some authorities predicting transformational opportunities while others see existential threats. Smith Anderson hosted The Triangle North Carolina Chapter of the British-American Business Council for a panel discussion on the topic which explored the economic opportunities and challenges related to AI, in both North Carolina and the United Kingdom, with focus on its application in the biopharma and healthcare industries. The diverse panel discussed some of the benefits and risks associated with AI in this rapidly evolving landscape. Smith Anderson attorney Victoria Hartmann also added perspective on the legal issues arising in AI in life sciences and healthcare.
Panel: Artificial Intelligence in the Life Sciences and Healthcare Industries
- Moderator: Marinela Profi, SAS, Product Strategy Lead for Generative AI Solutions
- Virginia Clay, Morgan Stanley, breast cancer survivor and patient advocate
- Stefan Stryker, Calidar Cofounder/CEO
- Phaedra Boinodiris, IBM Consulting’s Global Leader for Responsible AI
- Nick Spittal, Velocity Clinical Research COO
Legal Issues Arising in AI in Life Sciences/Healthcare: Victoria Hartmann, Smith Anderson
A recording of the discussion can be viewed below.
